Masimo | MASI - Market Capitalization


Masimo reported $9.28B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Align Technology USD 11.2B 2.13B Dec/2025
AngioDynamics USD 278M 102M Jun/2025
AtriCure USD 1.97B 215M Dec/2025
Avanos Medical USD 648M 127M Mar/2026
Baxter International USD 9.82B 1.87B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Boston Scientific USD 141.35B 3.31B Dec/2025
Dexcom USD 25.88B 503M Dec/2025
Edwards Lifesciences USD 49.47B 3.81B Dec/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Globus Medical USD 12.64B 954M Mar/2026
Haemonetics USD 3.76B 1.44B Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
Intuitive Surgical USD 200.77B 40.45B Dec/2025
Masimo USD 9.28B 2.44B Mar/2026
Owens Minor USD 371M 326M Sep/2025
ResMed USD 35.16B 4.79B Dec/2025
Steris USD 24.88B 511M Dec/2025
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Zimmer Biomet Holdings USD 17.82B 1.69B Dec/2025